These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists]. Vignini M; Pelfini C; Montanari L Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466 [No Abstract] [Full Text] [Related]
5. Cyclic cyproterone/ethinyloestradiol in acne. Bye P Lancet; 1983 Oct; 2(8355):910-1. PubMed ID: 6137719 [No Abstract] [Full Text] [Related]
9. Clinical trial of cyproterone acetate-ethinyl oestradiol compound on androgen dependent skin disorders. Pai IF; Wu YC; Lu YC Taiwan Yi Xue Hui Za Zhi; 1982 Aug; 81(8):1048-55. PubMed ID: 6217284 [No Abstract] [Full Text] [Related]
10. European Commission orders France to lift ban on acne pill. Arie S BMJ; 2013 Aug; 347():f4932. PubMed ID: 23918671 [No Abstract] [Full Text] [Related]
11. Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study. Carlborg L Acta Obstet Gynecol Scand Suppl; 1986; 134():29-32. PubMed ID: 2949481 [TBL] [Abstract][Full Text] [Related]
12. [Use of cyproterone acetate in the treatment of acne]. Piquero MartÃn J; Acosta H Med Cutan Ibero Lat Am; 1982; 10(4):261-6. PubMed ID: 6222232 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen]. Lebeau M; Vokaer R J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):715-21. PubMed ID: 4267704 [No Abstract] [Full Text] [Related]
14. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive]. Mehrl J Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600 [No Abstract] [Full Text] [Related]
15. [Decrease of the sebum excretion rate and improvement of acne in acneic women treated with the association: cyproterone acetate-ethinyl estradiol (author's transl)]. Lehucher-Ceyrac D; Weber-Buisset MJ; Saurat JH Ann Dermatol Venereol; 1981; 108(11):861-8. PubMed ID: 6459747 [TBL] [Abstract][Full Text] [Related]
16. [Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate]. Audebert A; Emperaire JC; Gauthier A; Hallonet P; Hedon B; Lopes P; Quereux C; Roulier R Rev Fr Gynecol Obstet; 1991 Nov; 86(11):697-9. PubMed ID: 1838208 [TBL] [Abstract][Full Text] [Related]
17. Acne vulgaris. The past. The present and the future. Cunliffe WJ Acta Derm Venereol Suppl (Stockh); 1985; 120():34-8. PubMed ID: 2939675 [No Abstract] [Full Text] [Related]
18. Treatment of acne vulgaris with cyproterone acetate and ethinyl estradiol. van Velde JL Dermatologica; 1977; 155(3):143-6. PubMed ID: 142667 [TBL] [Abstract][Full Text] [Related]
19. Effect of cyproterone acetate-ethinyl estradiol treatment on the proportions of linoleic and sebaleic acids in various skin surface lipid classes. Stewart ME; Greenwood R; Cunliffe WJ; Strauss JS; Downing DT Arch Dermatol Res; 1986; 278(6):481-5. PubMed ID: 2947544 [TBL] [Abstract][Full Text] [Related]
20. Treatment of hirsutism and acne with cyproterone acetate. Miller JA; Jacobs HS Clin Endocrinol Metab; 1986 May; 15(2):373-89. PubMed ID: 2941191 [No Abstract] [Full Text] [Related] [Next] [New Search]